There are 2789 resources available
326P - National multicentre retrospective study on metastatic breast cancer patients to characterize long responder under eribulin: LORELINE study
Presenter: Marie Ange Mouret Reynier
Session: ePoster Display
327P - Predictors of progression-free survival in patients with metastatic breast cancer receiving palbociclib with letrozole
Presenter: Roya Behrouzi
Session: ePoster Display
485P - A phase Ib study of cetuximab combined with fruquintinib in the previously treated RAS/BRAF wild-type metastatic colorectal cancer: The preliminary result of CEFRU study
Presenter: YONG LI
Session: ePoster Display
317P - Survival analysis and prognostic factors in patients with metastatic breast cancer and oligometastatic disease
Presenter: Gema Marin Zafra
Session: ePoster Display
318P - Impact of right dose vs on-time chemotherapy on PFS in patients suffering from metastatic breast cancer
Presenter: Anudeep Padakanti
Session: ePoster Display
319P - A propensity score weighted study comparing two versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer
Presenter: Herve Bischoff
Session: ePoster Display
320P - Prognostic role of meningeal carcinomatosis in breast cancer
Presenter: Renata Meneguetti
Session: ePoster Display
992P - Pan-cancer T-cell priming transcriptomic markers reveals interpatient immunomic heterogeneity independent of histologic type
Presenter: Hirotakka Miyashita
Session: ePoster Display
993P - Glycolytic tumor burden on pretreatment 18F-FDG PET/CT correlates with response and survival in metastatic NSCLC undergoing immune checkpoint inhibitors
Presenter: Saulo Silva
Session: ePoster Display
994P - PCR-based analysis of PD-L1 RNA expression in lung cancer: Comparison with commonly utilized immunohistochemical assays
Presenter: Evgeny Imyanitov
Session: ePoster Display